Americas Gold and Silver Provides Q1-2024 Production Results; Appoints Jim Currie as Chief Operating Officer
Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.
Stay updated with breaking news from Chief Operating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.
/PRNewswire/ -- The National Organization for Rare Disorders (NORD) announced today that Pamela K. Gavin has been named CEO, effective immediately. She...
United Therapeutics impresses with record-breaking Q1 results. Revenue soars 34% Y/Y to $677.7 million, EPS jumps to $6.17. Tyvaso leads the charge with a 56% revenue surge.
On Wednesday, United Therapeutics Corporation (NASDAQ:UTHR) reported first-quarter sales of $677.7 million, up 34% year over year, beating the consensus of $623.9 million. The company reported EPS of $6.17, up from $4.86 a year ago, surpassing the consensus of $5.56. “The first quarter of 2024 represents another quarter of record revenue and double-digit year-over-year revenue growth,” jointly said Martine Rothblatt, Chairperson and Chief Executive Officer and Michael Benkowitz, President and Ch
SMG earnings call for the period ending March 31, 2024.